What is it about?
Lipid composition of liposomes that carry chemotherapeutic agents can differ a great deal, with resulting differences in pharmacokinetics, and many other parameters. However, when similar names are chosen, confusion ensues.
Featured Image
Read the Original
This page is a summary of: A tale of the two PEGylated liposomal doxorubicins, OncoTargets and Therapy, July 2015, Dove Medical Press,
DOI: 10.2147/ott.s79089.
You can read the full text:
Contributors
The following have contributed to this page
